Pine Pharmaceuticals, LLC recalls Moxifloxacin in Balanced Salt Solution, Solution for Intraocular Injection, 600 mcg/0.4mL (150 mcg/0.1mL) Syringe, Rx on
Recalled October 25, 2023 · FDA recall D-0056-2024 · Pine Pharmaceuticals
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
2484 syringes
Sold at
Nationwide within the United States
Description
Lack of Assurance of Sterility
Product
Moxifloxacin in Balanced Salt Solution, Solution for Intraocular Injection, 600 mcg/0.4mL (150 mcg/0.1mL) Syringe, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Manufacturer(s)
Pine Pharmaceuticals, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →